Skip to main content
These products are not intended to diagnose, treat, cure, or prevent any disease. Research compounds are sold for laboratory and educational purposes only.
These products are not intended to diagnose, treat, cure, or prevent any disease. Research compounds are sold for laboratory and educational purposes only.
Nasal - PT-141 / Oxytocin / Tesamorelin 10mg / 3mg / 10mg

Nasal – PT-141 / Oxytocin / Tesamorelin 10mg / 3mg / 10mg

$304.00

467 in stock

467 in stock

  • Name:
    Bremelanotide / Oxytocin / Tesamorelin Combination (Melanocortin Agonist – Neuropeptide – GHRH Analog Complex)
  • Sequence:
    PT-141 Sequence: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
    Oxytocin Sequence: Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly–NH₂
    Tesamorelin Sequence: Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Val–Leu–Ala–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg–Gln–Gln–Gly–Glu–Ser–Asn–Gln–Glu–Gln–His–Ala–Val–Ser–Ser–Tyr–Arg–Ala–Leu–Gly–Ser–Leu–Gln–Asp–Ile–Leu–Asn–Ser–NH₂
  • Molecular Formula:
    PT-141 Molecular Formula: C₅₀H₆₈N₁₄O₁₀
    Oxytocin Molecular Formula: C₄₃H₆₆N₁₂O₁₂S₂
    Tesamorelin Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  • Molecular Weight:
    PT-141 Molecular Weight: ≈ 1025.2 g/mol
    Oxytocin Molecular Weight: ≈ 1007.19 g/mol
    Tesamorelin Molecular Weight: ≈ 5135.9 g/mol
  • CAS Registry Number:
    PT-141 (189691-06-3)
    Oxytocin (50-56-6)
    Tesamorelin (218949-48-5)

PT-141 / Oxytocin / Tesamorelin – ADVANCED MULTI-AXIS RESEARCH PEPTIDE SYSTEM FOR NEUROENDOCRINE, SEXUAL FUNCTION, AND METABOLIC SIGNALING STUDIES

Scientific Overview of PT-141 / Oxytocin / Tesamorelin

This triple-pathway research formulation integrates three distinct neuroendocrine peptides—PT-141 (Bremelanotide), Oxytocin, and Tesamorelin—to facilitate advanced studies on melanocortin signaling, hypothalamic-pituitary axis modulation, and metabolic hormone regulation.

PT-141 (Bremelanotide)

A synthetic analog of α-MSH, PT-141 is a potent melanocortin-3 and -4 receptor agonist (MC3R/MC4R) that influences hypothalamic and limbic activity. Research models focus on:

• Central sexual arousal mechanisms via MC4R-mediated dopaminergic signaling (Wessells et al., 2000).
• Reward and motivation circuits independent of peripheral nitric oxide pathways (Diamond et al., 2004).
• Behavioral neuroendocrinology examining stress, desire, and receptor cross-modulation.

Oxytocin

A cyclic nonapeptide neurohormone, Oxytocin acts on OXTR receptors in the brain and periphery, serving as a key research agent for:

• Social cognition and emotional bonding (Insel & Young, 2001).
• HPA axis suppression and stress recovery (Heinrichs et al., 2003).
• Synergistic signaling with melanocortin and GHRH pathways in behavioral-endocrine regulation.

Tesamorelin

A synthetic growth hormone–releasing hormone (GHRH) analog, Tesamorelin stimulates pituitary GH secretion through GHRH receptor activation, promoting IGF-1 synthesis and lipid metabolism.

Research applications include:

• GH-axis regulation and pituitary function mapping (Bowers et al., 2008).
• Metabolic and lipolytic response studies in aging, obesity, and muscle physiology models.
• Neuroendocrine interaction with other hypothalamic peptides, exploring feedback control within energy and reproductive systems.

Combined Research Applications

In integrated neuroendocrine models, the PT-141 / Oxytocin / Tesamorelin system enables exploration of:

• Hypothalamic multi-receptor signaling involving MC4R, OXTR, and GHRH receptors.
• Cross-modulation of sexual function, emotional response, and growth hormone dynamics.
• Peptide network synergy within the broader neurobehavioral and metabolic control systems.

This triple formulation represents a comprehensive research tool for studying the interplay between behavioral, hormonal, and metabolic signaling axes—bridging peptide endocrinology, neurobiology, and receptor pharmacology.

COAs

COA_Nasal_PTO10310N1125

*This peptide is intended solely for laboratory research use. It is not approved for human consumption or therapeutic application.

Skip to content